NuCana plc - American Depositary Share (NCNA) Social Stream



NuCana plc - American Depositary Share (NCNA): $0.68

0.06 (+9.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NCNA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 391

in industry

NuCana plc (NCNA) Price Targets From Analysts

Use the tables below to see what analysts covering NuCana plc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-23 6 $22 $10 $18 $1.02 1664.71%
2021-11-24 6 $22 $9 $17.75 $1.02 1640.2%
2022-03-14 5 $22 $5 $14.25 $1.02 1297.06%

The Trend in the Analyst Price Target


NCNA's average price target has moved up $0.09 over the prior 16 months.

Over the past 29 weeks, NCNA's average upside potential has been 769.32%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-22 6 22 10 18.00 1.95 823.08%
2021-11-18 6 22 10 18.00 2.57 600.39%
2021-11-22 6 22 10 18.00 2.66 576.69%
2021-11-24 5 22 9 17.75 2.84 525%
2022-03-14 5 22 5 14.25 0.77 1750.65%

NCNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


NCNA's average broker recommendation rating worsened by 0.4 over the prior 30 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, NuCana plc's upside potential (average analyst target price relative to current price) is greater than 398.58% of them.
  • In the context of all US stocks, NuCana plc's variance in analysts' estimates is lower than -242.15% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, NuCana plc's average analyst price target is higher than 112.77% of them.
  • NCNA has a greater number of analysts covering the stock than 283.52% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NuCana plc are NBTX, NATR, and MTP.

Is NCNA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5429 seconds.